Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Guillain-Barré syndrome and COVID-19 in Italy

Sabrina Ravaglia • 29 Apr 2020

Sabrina Ravaglia, MD, PhD, IRCCS C. Mondino Foundation, Pavia, Italy, discusses the association of Guillain-Barré syndrome with COVID-19 in Italy. Five patients across three northern Italian hospitals were examined. Neurological symptoms manifested 5-10 days after the initial COVID-19 symptoms. Additionally, severe axonal impairment was detected during medical induction studies and the patients had a poor response to immunoglobulin treatment. The patients had a poor prognosis and experienced respiratory failure due to respiratory muscle weakness. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.